KLOW 80mg - single vial

$40.00

KLOW is a multi-peptide recovery blend containing 10 mg BPC-157, 10 mg TB-500, 50 mg GHK-Cu, and 10 mg KPV. The formulation is designed to support tissue repair, recovery, inflammation control, skin health, and wound healing. Each component contributes a different mechanism:

  • BPC-157: Tendon, ligament, muscle, and gastrointestinal repair

  • TB-500: Systemic tissue regeneration and recovery

  • GHK-Cu: Collagen production, skin rejuvenation, wound healing, and antioxidant support

  • KPV: Potent anti-inflammatory peptide derived from α-MSH with benefits for inflammation and gut health

Common Research Dosing Protocol:

  • 0.2-0.5 mL daily subcutaneously

  • Most common starting dose: 0.25 mL daily

  • Typical cycle length: 4-12 weeks

Administration:

  • Subcutaneous injection

  • Can be administered once daily

  • Often used during injury recovery, post-surgical healing, or periods of heavy training

Storage:

  • Refrigerate at 36-46°F (2-8°C) after reconstitution

  • Protect from light

  • Do not freeze

  • Use sterile technique for all withdrawals

Notes:
KLOW is often viewed as an "all-in-one recovery blend" because it combines localized healing (BPC-157), systemic repair (TB-500), regenerative and cosmetic benefits (GHK-Cu), and inflammation control (KPV). Users commonly employ it for tendon injuries, joint discomfort, post-operative recovery, skin quality improvements, and general recovery enhancement.

Example Reconstitution:
If reconstituted with 10 mL bacteriostatic water, each 0.25 mL (25-unit insulin syringe mark) provides approximately:

  • BPC-157: 250 mcg

  • TB-500: 250 mcg

  • GHK-Cu: 1.25 mg

  • KPV: 250 mcg

This makes 0.25-0.5 mL daily a practical range for most research protocols.

KLOW is a multi-peptide recovery blend containing 10 mg BPC-157, 10 mg TB-500, 50 mg GHK-Cu, and 10 mg KPV. The formulation is designed to support tissue repair, recovery, inflammation control, skin health, and wound healing. Each component contributes a different mechanism:

  • BPC-157: Tendon, ligament, muscle, and gastrointestinal repair

  • TB-500: Systemic tissue regeneration and recovery

  • GHK-Cu: Collagen production, skin rejuvenation, wound healing, and antioxidant support

  • KPV: Potent anti-inflammatory peptide derived from α-MSH with benefits for inflammation and gut health

Common Research Dosing Protocol:

  • 0.2-0.5 mL daily subcutaneously

  • Most common starting dose: 0.25 mL daily

  • Typical cycle length: 4-12 weeks

Administration:

  • Subcutaneous injection

  • Can be administered once daily

  • Often used during injury recovery, post-surgical healing, or periods of heavy training

Storage:

  • Refrigerate at 36-46°F (2-8°C) after reconstitution

  • Protect from light

  • Do not freeze

  • Use sterile technique for all withdrawals

Notes:
KLOW is often viewed as an "all-in-one recovery blend" because it combines localized healing (BPC-157), systemic repair (TB-500), regenerative and cosmetic benefits (GHK-Cu), and inflammation control (KPV). Users commonly employ it for tendon injuries, joint discomfort, post-operative recovery, skin quality improvements, and general recovery enhancement.

Example Reconstitution:
If reconstituted with 10 mL bacteriostatic water, each 0.25 mL (25-unit insulin syringe mark) provides approximately:

  • BPC-157: 250 mcg

  • TB-500: 250 mcg

  • GHK-Cu: 1.25 mg

  • KPV: 250 mcg

This makes 0.25-0.5 mL daily a practical range for most research protocols.